Abstract
Central Nervous System Agents in Medicinal Chemistry
Title: Author Index To Volume 6
Volume: 7 Issue: 1
Abstract:
Export Options
About this article
Cite this article as:
Author Index To Volume 6, Central Nervous System Agents in Medicinal Chemistry 2007; 7 (1) . https://dx.doi.org/10.2174/187152407780059268
DOI https://dx.doi.org/10.2174/187152407780059268 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Appraisal of Anti-Arthritic and Anti-Inflammatory Potential of Folkloric
Medicinal Plant <i>Peganum harmala</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer’s Disease
Current Alzheimer Research The Progress of Epilepsy after Stroke
Current Neuropharmacology Synaptic Elimination in Neurological Disorders
Current Neuropharmacology Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease
Current Alzheimer Research Noncoding Variants Functional Prioritization Methods Based on Predicted Regulatory Factor Binding Sites
Current Genomics Towards a Causal Model for Disgust in the Anxiety Disorders: An Integration of Evidence from Neuroscience
Current Psychiatry Reviews Anticonvulsant Activity of New GABA Prodrugs
Medicinal Chemistry Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors
Current Gene Therapy Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats
CNS & Neurological Disorders - Drug Targets Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia
Central Nervous System Agents in Medicinal Chemistry Tachykinins as Therapeutic Targets in Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Humic Acids as Therapeutic Compounds in Lead Intoxication
Current Clinical Pharmacology Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Green Tea Extract-Patents and Diversity of Uses
Recent Patents on Food, Nutrition & Agriculture Editorial [Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. PART I. (Executive Editors: Calogero Caruso Thea Magrone and Emilio Jirilllo)]
Current Pharmaceutical Design Statin-Like Drugs for the Treatment of Brain Cholesterol Loss in Alzheimers Disease
Current Drug Safety Role of Amylin and its Receptors in Neurodegeneration
Current Protein & Peptide Science Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry